Stephen Miller

Affiliations: 
Northwestern University, Evanston, IL 
Area:
Molecular Neuroscience, Neurobiology of Disease, Neuroimmunology
Google:
"Stephen Miller"
Mean distance: 7633.29
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Arellano G, Loda E, Chen Y, et al. (2023) Interferon-γ controls aquaporin-4-specific Th17 and B cells in neuromyelitis optica spectrum disorder. Brain : a Journal of Neurology
Titus HE, Xu H, Robinson AP, et al. (2022) Repurposing the cardiac glycoside digoxin to stimulate myelin regeneration in chemically-induced and immune-mediated mouse models of multiple sclerosis. Glia
Podojil JR, Genardi S, Chiang MY, et al. (2022) Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice. Journal of Immunology (Baltimore, Md. : 1950)
Loda E, Arellano G, Perez-Giraldo G, et al. (2021) Can Immune Tolerance Be Re-established in Neuromyelitis Optica? Frontiers in Neurology. 12: 783304
Neef T, Ifergan I, Beddow S, et al. (2021) Tolerance Induced by Antigen-Loaded PLG Nanoparticles Affects the Phenotype and Trafficking of Transgenic CD4 and CD8 T Cells. Cells. 10
Qian Y, Arellano G, Ifergan I, et al. (2021) ZEB1 promotes pathogenic Th1 and Th17 cell differentiation in multiple sclerosis. Cell Reports. 36: 109602
Neef T, Miller SD. (2021) Novel delivery mechanisms for antigen-specific immunotherapy. Current Opinion in Endocrinology, Diabetes, and Obesity
Podojil JR, Ifergan I, Chiang MY, et al. (2020) Methodology for Assessment of Human T Cell Activation and Blockade. Bio-Protocol. 10: e3644
Titus HE, Chen Y, Podojil JR, et al. (2020) Pre-clinical and Clinical Implications of "Inside-Out" vs. "Outside-In" Paradigms in Multiple Sclerosis Etiopathogenesis. Frontiers in Cellular Neuroscience. 14: 599717
Morris AH, Hughes KR, Oakes RS, et al. (2020) Engineered immunological niches to monitor disease activity and treatment efficacy in relapsing multiple sclerosis. Nature Communications. 11: 3871
See more...